EQT Private Equity

Stories

EQT agrees to take QIAGEN private in all-cash takeover offer

Acquirer making the takeover offer through its EQT XI fund

Swedish buyout firm EQT Private Equity agreed to buy Dutch molecular diagnostics company QIAGEN for €46.50 per share in cash. The offer is a 40.3% premium to QIAGEN's share price before takeover reports surfaced in July, and values the company at about €10.8 billion including roughly $1.1 billion in net debt.

Updated 1 hour ago